SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BORTOLUZZI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.583
AS - Asia 7.355
EU - Europa 3.241
SA - Sud America 1.201
AF - Africa 464
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 22.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.181
SG - Singapore 2.480
CN - Cina 1.349
IT - Italia 1.022
BR - Brasile 815
VN - Vietnam 661
HK - Hong Kong 613
BD - Bangladesh 451
DE - Germania 426
GB - Regno Unito 378
ID - Indonesia 323
FR - Francia 287
JP - Giappone 254
IN - India 251
EG - Egitto 234
TR - Turchia 227
FI - Finlandia 219
UA - Ucraina 175
CA - Canada 171
RU - Federazione Russa 167
IQ - Iraq 161
MX - Messico 161
AR - Argentina 102
EC - Ecuador 95
NL - Olanda 88
SE - Svezia 87
PH - Filippine 82
PL - Polonia 82
ZA - Sudafrica 73
AU - Australia 72
PK - Pakistan 71
ES - Italia 60
SA - Arabia Saudita 58
IR - Iran 56
TW - Taiwan 51
CO - Colombia 50
MY - Malesia 50
AT - Austria 38
VE - Venezuela 35
PE - Perù 34
IE - Irlanda 33
KE - Kenya 33
KR - Corea 32
CL - Cile 31
BE - Belgio 29
UZ - Uzbekistan 26
DZ - Algeria 24
BO - Bolivia 21
NG - Nigeria 20
TH - Thailandia 20
HU - Ungheria 19
MA - Marocco 19
JO - Giordania 18
RO - Romania 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
IL - Israele 16
LT - Lituania 15
NZ - Nuova Zelanda 13
AE - Emirati Arabi Uniti 12
GR - Grecia 12
PT - Portogallo 12
CR - Costa Rica 11
KZ - Kazakistan 11
CH - Svizzera 10
LB - Libano 10
DK - Danimarca 9
HN - Honduras 9
JM - Giamaica 9
NP - Nepal 9
PS - Palestinian Territory 9
KW - Kuwait 8
NO - Norvegia 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
DO - Repubblica Dominicana 6
OM - Oman 6
AL - Albania 5
LK - Sri Lanka 5
LY - Libia 5
MM - Myanmar 5
NI - Nicaragua 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
ET - Etiopia 4
GT - Guatemala 4
HR - Croazia 4
KH - Cambogia 4
PR - Porto Rico 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BF - Burkina Faso 3
BH - Bahrain 3
CG - Congo 3
CU - Cuba 3
CY - Cipro 3
KG - Kirghizistan 3
Totale 22.870
Salva come PNG Salva come JPEG
Città #
Singapore 1.438
Ashburn 1.437
Fairfield 893
San Jose 757
Santa Clara 609
Hong Kong 571
Woodbridge 569
Beijing 451
Dallas 393
Houston 372
Seattle 352
Chandler 303
Cambridge 296
Wilmington 285
Los Angeles 249
Ho Chi Minh City 231
Ann Arbor 224
Council Bluffs 215
New York 206
Tokyo 203
Jakarta 191
Jacksonville 172
Hanoi 161
Lauterbourg 135
Helsinki 131
Ferrara 119
Princeton 115
Izmir 109
Munich 104
Nanjing 85
Baghdad 81
Shanghai 81
São Paulo 76
San Diego 71
Warsaw 69
London 67
Cairo 66
Orem 65
Milan 64
Chicago 61
Alexandria 59
Mexico City 58
Buffalo 57
Montreal 52
Toronto 51
Frankfurt am Main 49
Rome 48
Bologna 42
Atlanta 41
Brooklyn 40
Boardman 38
Boston 38
Denver 36
The Dalles 36
Stockholm 34
Turku 34
Hefei 33
Quito 32
Rio de Janeiro 32
Da Nang 30
Naples 30
Dearborn 29
Haiphong 29
Johannesburg 29
Nuremberg 29
Tanta 29
Phoenix 28
San Francisco 27
Chennai 26
Falkenstein 26
Lappeenranta 26
Nairobi 26
Poplar 26
Ankara 25
Manchester 25
Moscow 25
Sydney 25
Dublin 24
Redwood City 24
Tianjin 24
Shenyang 23
Tashkent 23
Amsterdam 22
Brussels 22
Guayaquil 22
Riyadh 22
Istanbul 21
Nanchang 21
Medan 20
Mumbai 20
Verona 20
Athens 19
Bengaluru 19
Bremen 19
Jiaxing 18
Lahore 18
Miami 18
New Delhi 18
Taipei 18
Budapest 17
Totale 13.849
Salva come PNG Salva come JPEG
Nome #
Systemic lupus erythematosus: one year in review 2023 954
One year in review 2022: systemic lupus erythematosus 456
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 342
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 296
Novel insights into the management of rheumatoid arthritis: one year in review 2022 292
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 282
Osteoarthritis and its management - Epidemiology, nutritional aspects and environmental factors 268
Novel insights into the management of rheumatoid arthritis: one year in review 2023 267
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: Analysis of a large monocentric cohort with a long-term follow-up 247
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 242
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 240
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 238
Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound 237
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 226
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 222
One year in review 2020: systemic lupus erythematosus 221
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology 216
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 215
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 214
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center 210
Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study 209
Altered expression and function of P2X7 receptorin patients affected by Systemic Lupus Erythematosus (SLE) 207
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET 205
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study 198
Biological and synthetic target DMARDs in psoriatic arthritis 198
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 198
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 197
Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus 196
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 195
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 195
How I treat patients with adult onset Still's disease in clinical practice 194
The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatic 193
PHARMACOLOGICAL ROLE OF A2A ADENOSINE RECEPTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS, CLINICAL AND LABORATORY CORRELATIONS 192
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 190
One year in review 2021: systemic lupus erythematosus 190
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 188
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 182
Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus 181
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 177
Overlap fra neuro-LES e sindromi demielinizzanti 177
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 176
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 176
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 175
Italian Society of Rheumatology recommendations for the management of gout 170
Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides 170
Italian society for Rheumatology recommendations for the management of hand osteoarthritis 169
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 169
SNP (1513A > C AND 489C > T) OF P2X7 RECEPTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH SEROSITIS 165
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 164
Colour Duplex Ultrasonography in the Diagnosis and Management of Giant Cell Arteritis 163
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 159
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 159
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 156
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 156
Systemic lupus erythematosus: one year in review 2024 155
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 154
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 154
Comment on: Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: Time to untie the Gordian knot? 153
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 153
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 153
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 150
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 150
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 149
Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study 147
Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 147
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 147
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 146
Systemic lupus erythematosus: State of the art on clinical practice guidelines 146
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 145
One year in review 2018: novelties in the treatment of rheumatoid arthritis 143
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 142
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 139
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 139
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 138
COLOR DOPPLER ULTRASONOGRAPHY IN THE DIAGNOSIS AND MANAGEMENT OF GIANT CELL ARTERITIS. 136
Improved pregnancy outcome in patients with Rheumatoid Arthritis who followed an ideal clinical pathway 136
Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus 135
Adenosine and adenosine receptors in rheumatoid arthritis 134
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 133
Neurologic Involvement in Rheumatic Diseases 132
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 131
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 131
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 130
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 126
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 125
The Italian society for rheumatology clinical practice guidelines for rheumatoid arthritis 125
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 123
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products 122
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 121
Systemic lupus erythematosus: one year in review 2025 118
Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept 117
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 116
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 116
The Italian society for rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis 116
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 115
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment 115
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus:experience from a tertiary referral centre. 114
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 114
Single-photon-emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement. 112
The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout 112
Totale 18.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 352
Totale 110.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 0 0 90
2021/20221.183 101 99 61 50 43 49 86 97 50 68 83 396
2022/2023786 118 95 34 89 97 72 37 54 78 18 53 41
2023/20241.120 49 56 22 11 81 39 24 107 40 183 167 341
2024/20254.591 172 227 454 258 490 457 160 214 756 541 490 372
2025/202611.439 887 431 1.066 1.176 1.537 688 1.117 666 1.107 1.295 946 523
Totale 23.387